Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q99828
UPID:
CIB1_HUMAN
Alternative names:
Calcium- and integrin-binding protein; Calmyrin; DNA-PKcs-interacting protein; Kinase-interacting protein; SNK-interacting protein 2-28
Alternative UPACC:
Q99828; B5BU40; H6WJF3; O00693; O00735; Q6IB49; Q96J54; Q99971
Background:
Calcium and integrin-binding protein 1, known by alternative names such as Calmyrin and DNA-PKcs-interacting protein, plays a pivotal role in cellular processes including cell differentiation, proliferation, and apoptosis. It is crucial in bone marrow megakaryocyte differentiation, integrin signaling, and negatively regulates thrombopoietin-mediated signaling pathways. This protein is also involved in focal adhesion formation, cell migration on fibronectin, and acts as a negative regulator of stress-activated MAP kinase signaling pathways.
Therapeutic significance:
Given its involvement in Epidermodysplasia verruciformis 3, a condition leading to a high risk of skin carcinoma, understanding the role of Calcium and integrin-binding protein 1 could open doors to potential therapeutic strategies. Its regulatory role in angiogenesis and tumor growth, through mediating PKD/PRKD2-induced vascular endothelial growth factor A secretion, underscores its potential as a target in cancer therapy.